- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Entertainment and Media Litigation
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
December 5, 2024Jake Holdreith Named to Twin Cities Business Top 100
-
December 4, 2024Robins Kaplan Obtains $10.5 Million Post-Verdict in Landmark Aerosol Dust Remover Abuse Case
-
December 2, 2024Robins Kaplan LLP Announces 2025 Partners
-
December 12, 2024Strategies for Licensing AI: A Litigation Perspective
-
December 2024A Landmark Victory for Disabled Homeless Veterans: Q&A with the Trial Team
-
November 8, 2024Trademark tensions on the track: Court upholds First Amendment protections in Haas v. Steiner
-
November 8, 2024Destination Skiing And The DOJ's Mountain Merger Challenge
-
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
-
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
-
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Reached Settlements in Excess of $118 Million in Disposable Contact Lens Antitrust Litigation
October 12, 2022
In re: Disposable Contact Lens Antitrust Litigation, 15-md-02626 (M.D. Fla.)
As court-appointed co-lead counsel, Robins Kaplan LLP reached settlements in excess of $118 million on behalf of U.S. contact lens purchasers, resolving an expansive antitrust class action against the four dominant manufacturers and the largest nationwide distributor of contact lenses.
The firm filed one of the first class action complaints in March 2015, alleging a conspiracy by Johnson & Johnson, CooperVision, Alcon, Bausch + Lomb, and wholesale distributor ABB Optical Group to stifle competition from discount retailers and fix prices in the $4 billion contact lens market serving 40 million Americans. Plaintiffs allege that defendants illegally imposed minimum retail prices for many popular brands of contact lenses, and that in doing so, they violated federal antitrust laws, as well as state consumer protection and antitrust laws.
Robins Kaplan achieved an ice-breaker settlement with CooperVision, Inc. in February of 2018, and a $10 million follow-on settlement with Bausch & Lomb, Inc. in August of 2019, both of which received final approval in 2020. In December of 2018, plaintiffs were granted class certification, and in November of 2019, plaintiffs defeated defendants’ motions for summary judgment. In August of 2020, Robins Kaplan and its co-leads settled with ABB for $30.2 million, which received final approval in June of 2021. In March of 2022, days before trial was scheduled to begin, Robins Kaplan reached settlements totaling $75 million with the final two defendants—Johnson & Johnson Vision Care and Alcon Vision—which received final court approval in October of 2022 and resolved the long-running antitrust class action in its entirety.
Related Professionals
Similar Results
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.